WASHINGTON, Nov. 8, 2018 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it
will participate at the following upcoming investor conferences in
November 2018:
The Stifel 2018 Healthcare Conference in New York City on Tuesday, November 13, 2018. A corporate
presentation is scheduled for 2:00 p.m.
Eastern Time.
The Jefferies 2018 London Healthcare Conference in London, England on Thursday, November 15, 2018. A corporate
presentation is scheduled for 4:40
p.m. Greenwich Mean Time (11:40 a.m.
Eastern Time).
The corporate presentations given at the Stifel and Jefferies
conferences will be available live on Vanda's corporate website,
where they also will be archived for 30 days. To access the
presentations, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2018-investor-conferences-300747185.html
SOURCE Vanda Pharmaceuticals Inc.